CSI Market
Sign In | Register

Xilio Therapeutics Inc (XLO) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access XLO Annual Balance Sheets →
From Xilio Therapeutics Inc through Jun 30 2025, shifts in Jun 30 2026's assets and liabilities provide insight into the company's capital structure and financial stability.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent136.04
Cash & Short-term Investments136.00
Other Current Assets6.00
Prepaid Expense And Other Assets Current3.43
Total Current Assets145.47
Equipment/Property/Plant Net12.77
Other Assets, Noncurrent0.00
License Agreement Receivable-
Collaboration And License Agreement Receivable-
Restricted Cash Noncurrent1.81
Operating Lease Right Of Use Asset3.79
Total Assets154.25
Liabilities
Accounts Payable, Current AC2.32
Accrued Liabilities, Current AC7.85
Other Liabilities, Current0.00
Deferred Revenue, Current DE35.32
Total Current Liabilities34.20
Total Long-term Debt0.00
Deferred Revenue, Noncurrent DE12.72
Other liabilities, Noncurrent23.79
Operating Lease Liability Current1.38
Operating Lease Liability Noncurrent5.25
Total Liabilities81.99
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock506.95
Retained Earnings / Accumulated Deficit-434.69
Defined Benefit Plan and Other30.20
Other Equity0.00
Common Stockholder's Equity72.26
Total Stockholder's Equity72.26
Liabilities & Stockholder's Equity154.25
4 historic quarters locked

Sign in to unlock the full Xilio Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Xilio Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 12, 2026
  • Source: xlo-20260630.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-345759

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.